clinical study reports - Robuta Search

https://forums.mhra.gov.uk/forumdisplay.php?24-Regulatory-documents-(including-protocol-clinical-study-reports-and-publications)&s=707ce741963db62db0c1b89d2339d226 Regulatory documents (including protocol, clinical study reports and publications) clinical study reports regulatory documents including protocol publications https://forums.mhra.gov.uk/forumdisplay.php?24-Regulatory-documents-(including-protocol-clinical-study-reports-and-publications)&s=fdf3f5f241fefb7d49797b4a98ad435f Regulatory documents (including protocol, clinical study reports and publications) clinical study reports regulatory documents including protocol publications https://www.clinicaltrialsarena.com/uncategorized/newsperegrine-reports-top-line-results-from-phase-ii-pancreatic-cancer-study/ Peregrine reports top-line results from Phase II pancreatic cancer study - Clinical Trials Arena Feb 13, 2013 - Peregrine Pharmaceuticals has reported top-line results from a Phase II study evaluating bavituximab in combination with gemcitabine in stage IV pancreatic... https://www.clinicaltrialsarena.com/uncategorized/newsaprea-reports-positive-results-from-apr-246-investigational-cancer-drug-study/ Aprea reports positive results from APR-246 investigational cancer drug study - Clinical Trials... Sep 19, 2012 - Aprea, a Karolinska Development portfolio company, has reported positive clinical data of its investigational drug, APR-246, from a Phase I/II study.